Article Versions Notes

Plesca I, Benešová I, Beer C, Sommer U, Müller L, Wehner R, Heiduk M, Aust D, Baretton G, Bachmann MP, et al. Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma. Cancers. 2022; 14(5):1216. https://doi.org/10.3390/cancers14051216

Plesca, Ioana, Iva Benešová, Carolin Beer, Ulrich Sommer, Luise Müller, Rebekka Wehner, Max Heiduk, Daniela Aust, Gustavo Baretton, Michael P Bachmann, and et al. 2022. "Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma" Cancers 14, no. 5: 1216. https://doi.org/10.3390/cancers14051216

Plesca, I., Benešová, I., Beer, C., Sommer, U., Müller, L., Wehner, R., Heiduk, M., Aust, D., Baretton, G., Bachmann, M. P., Feldmann, A., Weitz, J., Seifert, L., Seifert, A. M., & Schmitz, M. (2022). Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma. Cancers, 14(5), 1216. https://doi.org/10.3390/cancers14051216